People · Operator

Gene Gutman

Named in public records as an officer, director or promoter · active 2018–2022 · Healthtech, Other Health Care

2
Companies
5
Filings
$14.9M
Combined raised · real
Serial
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Child Health Imprints (CHIL) USA, Inc.HealthtechSeries A$9.7M$21.7M2021
Zenith Technical Innovations, LLCOther Health CareSeed$5.3M$37.2M2018
Operator network

Gene Gutman at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Harpreet Singh · 4 companies · 1 sharedHarpreet SinghJonathan Fritz · 2 companies · 1 sharedJonathan FritzLinda Wong · 2 companies · 1 sharedLinda WongRavneet Kaur · 2 companies · 1 sharedRavneet KaurEd Kopetsky · 1 companies · 1 sharedEd KopetskyGregory J Binversie · 1 companies · 1 sharedGregory J Binvers…John A Bucher · 1 companies · 1 sharedJohn A BucherKathryn J Clubb · 1 companies · 1 sharedKathryn J ClubbMark J Binversie · 1 companies · 1 sharedMark J BinversieRick J Zimbelman · 1 companies · 1 sharedRick J ZimbelmanRita J King · 1 companies · 1 sharedRita J KingWilliam W Sultan · 1 companies · 1 sharedWilliam W SultanChild Health Imprints (CHIL) USA, Inc. · $9.7M raisedChild Health Imprints…Zenith Technical Innovations, LLC · $5.3M raisedZenith Technical Inno…Gene GutmanGG
Gene Gutman Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Gene Gutman on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Harpreet Singh14
Jonathan Fritz12
Ravneet Kaur12
Linda Wong12
Rita J King11
Kathryn J Clubb11
Mark J Binversie11
William W Sultan11
Rick J Zimbelman11
John A Bucher11
Gregory J Binversie11
Ed Kopetsky11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.